Eri Kawashita Selected Research

3- (1- (4- phenoxyphenyl)- 3- (2- phenylethyl)- 1H- indol- 5- yl)propanoic acid

3/2016

ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eri Kawashita Research Topics

Disease

5	Fibrosis (Cirrhosis) 04/2022 - 01/2010
4	Sandhoff Disease (Sandhoff's Disease) 01/2016 - 08/2006
3	Inflammation (Inflammations) 01/2019 - 02/2016
2	Down Syndrome (Down's Syndrome) 01/2019 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2019 - 03/2016
1	Alcoholic Fatty Liver 04/2022
1	Weight Gain 01/2019
1	Fatty Liver 03/2016
1	Bone Resorption 01/2016
1	Cognitive Dysfunction 01/2016
1	Bone Diseases (Bone Disease) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2010
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 08/2006

Drug/Important Bio-Agent (IBA)

4	Group IV Phospholipases A2IBA 04/2022 - 02/2016
4	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2016 - 08/2006
2	CopperIBA 01/2019 - 01/2019
2	LipidsIBA 01/2019 - 03/2016
2	CholesterolIBA 01/2019 - 03/2016
2	Hexosaminidases (Hexosaminidase)IBA 01/2016 - 01/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2013 - 01/2010
2	OligosaccharidesIBA 01/2011 - 06/2009
2	beta-N-AcetylhexosaminidasesIBA 06/2009 - 08/2006
1	picric acid (picrate)IBA 04/2022
1	LysophospholipidsIBA 01/2019
1	EicosanoidsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	PropaneIBA 03/2016
1	PropionatesIBA 03/2016
1	SaltsIBA 03/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2016
1	3- (1- (4- phenoxyphenyl)- 3- (2- phenylethyl)- 1H- indol- 5- yl)propanoic acidIBA 03/2016
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Uridine Diphosphate (UDP)IBA 01/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	CalciumIBA 02/2013
1	Calcium-Independent Phospholipases A2IBA 02/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	ProstaglandinsIBA 02/2013
1	Phospholipases (Phospholipase)IBA 02/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	Prostaglandins FIBA 02/2013
1	ChemokinesIBA 01/2011
1	Dinoprostone (PGE2)FDA Link 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	AcetylglucosamineIBA 06/2009
1	Therapeutic UsesIBA 08/2006

Therapy/Procedure

2	Therapeutics 03/2011 - 01/2010